STOCK TITAN

[8-K] Element Solutions Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Universal Insurance Holdings, Inc. (UVE) filed a Form 4 for director Marlene Gordon covering a single transaction on 28 Jul 2025.

  • Security granted: 2,824 restricted common shares at $0 cost.
  • Post-grant ownership: 25,061 UVE shares held directly.
  • Vesting schedule: the restricted shares fully vest on 28 Jul 2026.

No derivative securities were involved, and the filing reports only one insider. Because the shares were awarded rather than purchased on the open market, the transaction mainly reflects compensation rather than incremental insider buying pressure. The size of the award is modest relative to UVE’s public float, but it modestly increases insider ownership and may modestly align the director’s incentives with shareholders.

Universal Insurance Holdings, Inc. (UVE) ha presentato un modulo Form 4 per la direttrice Marlene Gordon relativo a una singola transazione avvenuta il 28 luglio 2025.

  • Titoli assegnati: 2.824 azioni ordinarie vincolate a costo $0.
  • Possesso post-assegnazione: 25.061 azioni UVE detenute direttamente.
  • Calendario di maturazione: le azioni vincolate maturano completamente il 28 luglio 2026.

Non sono stati coinvolti titoli derivati e il modulo riporta un solo insider. Poiché le azioni sono state assegnate e non acquistate sul mercato aperto, la transazione riflette principalmente una forma di compensazione piuttosto che un aumento della pressione d'acquisto da parte degli insider. L'entità del premio è modesta rispetto al flottante pubblico di UVE, ma aumenta leggermente la partecipazione degli insider e può allineare in modo moderato gli interessi della direttrice con quelli degli azionisti.

Universal Insurance Holdings, Inc. (UVE) presentó un Formulario 4 para la directora Marlene Gordon que cubre una única transacción el 28 de julio de 2025.

  • Valores otorgados: 2,824 acciones comunes restringidas con un costo de $0.
  • Propiedad tras la concesión: 25,061 acciones de UVE en posesión directa.
  • Calendario de adquisición: las acciones restringidas se consolidan completamente el 28 de julio de 2026.

No se involucraron valores derivados y la presentación reporta solo un insider. Dado que las acciones fueron otorgadas y no compradas en el mercado abierto, la transacción refleja principalmente una compensación y no una presión adicional de compra por parte del insider. El tamaño del premio es modesto en relación con el flotante público de UVE, pero aumenta ligeramente la propiedad interna y puede alinear moderadamente los incentivos de la directora con los de los accionistas.

Universal Insurance Holdings, Inc. (UVE)는 이사 Marlene Gordon에 대해 2025년 7월 28일 단일 거래를 포함하는 Form 4를 제출했습니다.

  • 부여된 증권: 비용 $0로 제한된 보통주 2,824주.
  • 부여 후 소유권: 직접 보유한 UVE 주식 25,061주.
  • 베스팅 일정: 제한된 주식은 2026년 7월 28일에 완전히 베스팅됩니다.

파생 증권은 포함되지 않았으며, 제출서류에는 단 한 명의 내부자만 보고되었습니다. 주식이 공개 시장에서 구매된 것이 아니라 부여된 것이므로 이 거래는 주로 보상 성격이며 내부자의 추가 매수 압력을 반영하지 않습니다. 보상의 규모는 UVE의 공개 유통 주식 수에 비해 적당하지만 내부자 소유권을 다소 증가시키고 이사의 인센티브를 주주와 어느 정도 일치시킬 수 있습니다.

Universal Insurance Holdings, Inc. (UVE) a déposé un formulaire 4 pour la directrice Marlene Gordon concernant une transaction unique en date du 28 juillet 2025.

  • Titres attribués : 2 824 actions ordinaires restreintes à un coût de 0 $.
  • Possession après attribution : 25 061 actions UVE détenues directement.
  • Calendrier d'acquisition : les actions restreintes seront entièrement acquises le 28 juillet 2026.

Aucun titre dérivé n'a été impliqué, et le dépôt ne concerne qu'un seul initié. Comme les actions ont été attribuées et non achetées sur le marché ouvert, la transaction reflète principalement une compensation plutôt qu'une pression d'achat supplémentaire de la part de l'initié. La taille de l'attribution est modeste par rapport au flottant public de UVE, mais elle augmente légèrement la participation des initiés et peut modérément aligner les incitations de la directrice avec celles des actionnaires.

Universal Insurance Holdings, Inc. (UVE) reichte ein Formular 4 für die Direktorin Marlene Gordon ein, das eine einzelne Transaktion am 28. Juli 2025 abdeckt.

  • Gewährte Wertpapiere: 2.824 eingeschränkte Stammaktien zu Kosten von $0.
  • Besitz nach Gewährung: 25.061 UVE-Aktien, die direkt gehalten werden.
  • Vesting-Zeitplan: Die eingeschränkten Aktien werden am 28. Juli 2026 vollständig freigegeben.

Es waren keine derivativen Wertpapiere beteiligt, und die Meldung betrifft nur einen Insider. Da die Aktien vergeben und nicht auf dem freien Markt gekauft wurden, spiegelt die Transaktion hauptsächlich eine Vergütung wider und keinen zusätzlichen Kaufdruck durch Insider. Die Größe der Zuteilung ist im Verhältnis zum öffentlichen Streubesitz von UVE bescheiden, erhöht jedoch leicht den Insiderbesitz und kann die Anreize der Direktorin moderat mit denen der Aktionäre in Einklang bringen.

Positive
  • Increased insider ownership: Director now holds 25,061 shares, marginally strengthening management-shareholder alignment.
Negative
  • No open-market purchase: Shares were granted at $0, so the filing does not signal personal capital commitment.

Insights

TL;DR: Modest director stock grant; aligns incentives but not a strong bullish signal.

The grant of 2,824 restricted shares to Director Marlene Gordon boosts her stake to roughly 25 k shares. Because the award is cost-free and vests over one year, it functions as routine equity compensation rather than a discretionary purchase. While insider ownership rises, the absolute dollar value is likely immaterial to UVE’s market cap, so market impact should be limited. Investors may view the vesting schedule as a standard retention mechanism. Overall governance profile unchanged.

Universal Insurance Holdings, Inc. (UVE) ha presentato un modulo Form 4 per la direttrice Marlene Gordon relativo a una singola transazione avvenuta il 28 luglio 2025.

  • Titoli assegnati: 2.824 azioni ordinarie vincolate a costo $0.
  • Possesso post-assegnazione: 25.061 azioni UVE detenute direttamente.
  • Calendario di maturazione: le azioni vincolate maturano completamente il 28 luglio 2026.

Non sono stati coinvolti titoli derivati e il modulo riporta un solo insider. Poiché le azioni sono state assegnate e non acquistate sul mercato aperto, la transazione riflette principalmente una forma di compensazione piuttosto che un aumento della pressione d'acquisto da parte degli insider. L'entità del premio è modesta rispetto al flottante pubblico di UVE, ma aumenta leggermente la partecipazione degli insider e può allineare in modo moderato gli interessi della direttrice con quelli degli azionisti.

Universal Insurance Holdings, Inc. (UVE) presentó un Formulario 4 para la directora Marlene Gordon que cubre una única transacción el 28 de julio de 2025.

  • Valores otorgados: 2,824 acciones comunes restringidas con un costo de $0.
  • Propiedad tras la concesión: 25,061 acciones de UVE en posesión directa.
  • Calendario de adquisición: las acciones restringidas se consolidan completamente el 28 de julio de 2026.

No se involucraron valores derivados y la presentación reporta solo un insider. Dado que las acciones fueron otorgadas y no compradas en el mercado abierto, la transacción refleja principalmente una compensación y no una presión adicional de compra por parte del insider. El tamaño del premio es modesto en relación con el flotante público de UVE, pero aumenta ligeramente la propiedad interna y puede alinear moderadamente los incentivos de la directora con los de los accionistas.

Universal Insurance Holdings, Inc. (UVE)는 이사 Marlene Gordon에 대해 2025년 7월 28일 단일 거래를 포함하는 Form 4를 제출했습니다.

  • 부여된 증권: 비용 $0로 제한된 보통주 2,824주.
  • 부여 후 소유권: 직접 보유한 UVE 주식 25,061주.
  • 베스팅 일정: 제한된 주식은 2026년 7월 28일에 완전히 베스팅됩니다.

파생 증권은 포함되지 않았으며, 제출서류에는 단 한 명의 내부자만 보고되었습니다. 주식이 공개 시장에서 구매된 것이 아니라 부여된 것이므로 이 거래는 주로 보상 성격이며 내부자의 추가 매수 압력을 반영하지 않습니다. 보상의 규모는 UVE의 공개 유통 주식 수에 비해 적당하지만 내부자 소유권을 다소 증가시키고 이사의 인센티브를 주주와 어느 정도 일치시킬 수 있습니다.

Universal Insurance Holdings, Inc. (UVE) a déposé un formulaire 4 pour la directrice Marlene Gordon concernant une transaction unique en date du 28 juillet 2025.

  • Titres attribués : 2 824 actions ordinaires restreintes à un coût de 0 $.
  • Possession après attribution : 25 061 actions UVE détenues directement.
  • Calendrier d'acquisition : les actions restreintes seront entièrement acquises le 28 juillet 2026.

Aucun titre dérivé n'a été impliqué, et le dépôt ne concerne qu'un seul initié. Comme les actions ont été attribuées et non achetées sur le marché ouvert, la transaction reflète principalement une compensation plutôt qu'une pression d'achat supplémentaire de la part de l'initié. La taille de l'attribution est modeste par rapport au flottant public de UVE, mais elle augmente légèrement la participation des initiés et peut modérément aligner les incitations de la directrice avec celles des actionnaires.

Universal Insurance Holdings, Inc. (UVE) reichte ein Formular 4 für die Direktorin Marlene Gordon ein, das eine einzelne Transaktion am 28. Juli 2025 abdeckt.

  • Gewährte Wertpapiere: 2.824 eingeschränkte Stammaktien zu Kosten von $0.
  • Besitz nach Gewährung: 25.061 UVE-Aktien, die direkt gehalten werden.
  • Vesting-Zeitplan: Die eingeschränkten Aktien werden am 28. Juli 2026 vollständig freigegeben.

Es waren keine derivativen Wertpapiere beteiligt, und die Meldung betrifft nur einen Insider. Da die Aktien vergeben und nicht auf dem freien Markt gekauft wurden, spiegelt die Transaktion hauptsächlich eine Vergütung wider und keinen zusätzlichen Kaufdruck durch Insider. Die Größe der Zuteilung ist im Verhältnis zum öffentlichen Streubesitz von UVE bescheiden, erhöht jedoch leicht den Insiderbesitz und kann die Anreize der Direktorin moderat mit denen der Aktionäre in Einklang bringen.

0001590714FALSE00015907142025-07-302025-07-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________________________

FORM 8-K
________________________________________________________

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 30, 2025
________________________________________________________
Image1.jpg
Element Solutions Inc
________________________________________________________
(Exact name of registrant as specified in its charter)
Delaware001-3627237-1744899
(State or other jurisdiction
of incorporation)
(Commission File Number)(IRS Employer Identification No.)
500 East Broward Boulevard,Suite 186033394
Fort Lauderdale,Florida(Zip Code)
(Address of principal executive offices)
Registrant's telephone number, including area code:   (561) 207-9600

Not Applicable
________________________________________________________
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareESINew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02. Results of Operations and Financial Condition.

On July 30, 2025, Element Solutions Inc ("Element Solutions") issued a press release announcing its financial results for the three and six months ended June 30, 2025. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
To supplement the financial measures prepared in accordance with generally accepted accounting principles in the United States ("GAAP"), Element Solutions presents certain non-GAAP financial measures. Investors are encouraged to refer to the Non-GAAP Measures section in the press release for definitions and reconciliations of these non-GAAP measures.
The information in this Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any filing of Element Solutions, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing.
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.
The following exhibits are furnished herewith:
Exhibit NumberDescription
99.1
Press release, dated July 30, 2025, relating to the financial results of Element Solutions for the three and six months ended June 30, 2025 (furnished only)
104Cover Page Interactive Data File (formatted as Inline XBRL)(furnished only)




SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ELEMENT SOLUTIONS INC
  (Registrant)
July 30, 2025 /s/ Michael Russnok
(Date)Michael Russnok
 Chief Accounting Officer


FAQ

What did UVE report in the latest Form 4?

Director Marlene Gordon received 2,824 restricted shares of UVE common stock on 28 Jul 2025.

How many Universal Insurance (UVE) shares does the director now own?

After the grant, Gordon beneficially owns 25,061 shares directly.

When do the newly granted UVE shares vest?

The restricted shares vest in full on 28 Jul 2026.

Was the transaction an open-market buy or sale?

Neither; it was a restricted stock award at no cost.

Does the filing involve derivative securities?

No derivative securities were acquired or disposed of in this Form 4.
Element Solutions Inc

NYSE:ESI

ESI Rankings

ESI Latest News

ESI Latest SEC Filings

ESI Stock Data

5.61B
224.68M
7.83%
92.84%
0.65%
Specialty Chemicals
Miscellaneous Chemical Products
Link
United States
FORT LAUDERDALE